Arthritis, Gouty
Information
- Disease name
- Arthritis, Gouty
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05253833 | Active, not recruiting | Phase 2 | Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout | August 12, 2022 | August 2024 |
| NCT00549549 | Completed | Phase 3 | Celebrex In Acute Gouty Arthritis Study | February 2008 | December 2009 |
| NCT00663169 | Completed | Phase 2 | Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout | April 2008 | October 2009 |
| NCT05119686 | Completed | Phase 2 | Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients | November 16, 2021 | November 17, 2022 |
| NCT05966701 | Not yet recruiting | Phase 1 | The MAD Study of SSGJ-613 in Healthy Subjects | August 10, 2023 | March 10, 2024 |
| NCT06439602 | Recruiting | Phase 3 | Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients | June 2024 | November 2026 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015210